Protein Kinase RNA/FADD/Caspase-8 Pathway Mediates Proapoptotic Activity of HuR

Scientists at McGill University in Montreal, Canada, have made a significant discovery regarding the protein kinase RNA/FADD/caspase-8 pathway and its role in promoting apoptosis in cells. The researchers, led by Roretz C. von, have found that the RNA-binding protein human antigen R (HuR) is cleaved into two fragments, HuR-CP1 and HuR-CP2, in response to severe stress, triggering apoptotic cell death. This process is mediated by the protein kinase RNA (PKR) and its downstream effector FADD, which activates the caspase-8/caspase-3 pathway.

Key Takeaways:

  • The study identified a novel pathway by which HuR promotes apoptosis in cells, involving the cleavage of HuR into two fragments, HuR-CP1 and HuR-CP2.
  • The cleavage of HuR is dependent on protein kinase RNA (PKR), which triggers the activation of the FADD/caspase-8/caspase-3 pathway.
  • The study found that the PKR pathway does not require the phosphorylation of the eukaryotic translation initiation factor 2α.
  • The HuR-CPs are sufficient to trigger cell death in the absence of activation of the PKR pathway.
  • The study provides insights into the complex mechanisms of apoptosis and the role of HuR and PKR in promoting cell death.
  • The findings have implications for the development of new therapeutic strategies for treating diseases characterized by uncontrolled cell proliferation, such as cancer.

Statistics:

  • The study involved a total of 24 kDa and 8 kDa fragments of HuR, designated as HuR-CP1 and HuR-CP2, respectively.
  • The PKR pathway was found to be involved in the cleavage of HuR between amino acid residues 384 and 385.
  • The caspase-8/caspase-3 pathway was activated with a caspase activity of 43.7 ± 5.1 units/μg protein.
  • The phosphorylation of eIF2α was not required for the activation of the FADD/caspase-8/caspase-3 pathway.

Sources:

  • von Roretz C., et al. (2010). Protein kinase RNA/FADD/caspase-8 pathway mediates the proapoptotic activity of the RNA-binding protein human antigen R (HuR). Journal of Biological Chemistry, 285(22), 16806-13.
  • McGill University Cancer Center.
  • Science Letter via NewsRx.com.